Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)	Ear Diseases, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, gonadal disorder, head and neck cancer, hearing disorder, hearing loss disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, nervous system disorder, otorhinolaryngologic disease, testicular cancer, testicular disorder, thoracic cancer	Recruiting	Phase 1 / Phase 2	2026-06-18		NCT07407582

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fennec Pharma	1
University of Arizona	138

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Arizona Cancer Center	Tucson	United States	13